CTC Bio Inc. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
30,938
13,413
4,539
7,004
9,161
Total Accounts Receivable
38,944
34,518
35,903
35,137
30,738
Inventories
26,895
26,476
28,772
29,186
32,288
Other Current Assets
1,286
2,479
3,462
2,232
1,016
Total Current Assets
98,062
76,885
72,677
73,560
73,202
Net Property, Plant & Equipment
33,547
66,290
86,788
92,013
91,445
Total Investments and Advances
15,820
15,721
30,743
17,308
25,950
Long-Term Note Receivable
-
-
-
573
72
Intangible Assets
2,808
3,002
3,375
3,971
5,189
Other Assets
238
224
32
1,250
1,046
Total Assets
152,045
162,123
193,614
188,675
196,903
ST Debt & Current Portion LT Debt
37,391
46,277
54,966
62,033
49,553
Accounts Payable
7,371
6,315
6,789
8,995
10,303
Income Tax Payable
189
-
698
41
304
Other Current Liabilities
2,456
6,455
7,006
7,671
10,349
Total Current Liabilities
47,407
59,047
69,459
78,740
70,509
Long-Term Debt
6,806
10,310
17,283
14,007
45,795
Provision for Risks & Charges
3,049
3,905
4,699
4,307
6,313
Deferred Taxes
883
261
2,867
605
59
Other Liabilities
105
3,110
137
92
125
Total Liabilities
59,819
76,632
94,446
97,752
122,802
Common Equity (Total)
92,190
85,442
99,140
90,894
74,006
Total Shareholders' Equity
92,190
85,442
99,140
90,894
74,006
Total Equity
92,227
85,490
99,168
90,923
74,102
Liabilities & Shareholders' Equity
152,045
162,123
193,614
188,675
196,903
Accumulated Minority Interest
36
48
28
29
95

About CTC Bio

View Profile
Address
6th Floor, Sambo Building
Seoul SL 05724
Korea, Republic Of
Employees -
Website http://www.ctcbio.com
Updated 09/14/2018
CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. It operates through following divisions: Animal Health and Human Medicine. The Animal Health division produces antibiotic, enzyme, probiotic products and bird flu-related diagnostic kits and disinfectants.